This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
You’re stressed, I’m stressed; most of us have felt stress in the COVID-19 era which began in the U.S. Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S. in the first quarter of 2020.
people who are part of Native and Pacific Islander, American Indian and Alaska Native, Hispanic and Latinx, and Black (non-Hispanic) communities were more likely to have had a COVID-19 diagnosis in the first fourteen months of the pandemic than people were White or Asian citizens. of Hispanic and LatinX people (19% of U.S.
In the 19th and 20th centuries, segregated black hospitals were emblematic of separate but unequal health care,” begins the editorial introducing an entire issue of JAMA dedicated to racial and ethnic disparities and inequities in medicine and health care, published August 17, 2021. than on white people.
And, though vaccines are effective in reducing the likelihood of severe outcomes and death, data shows that this protection is not perfect — for example, in the first week of December 2021, nearly a quarter of COVID-19 deaths occurred in “fully” vaccinated people ( 682 of 2,912 deaths ). .
Over the summer of 2021, concern grew that the vaccines were not providing the near-perfect protection against symptomatic disease and transmission that had first emboldened the administration to jettison other public health measures. The entire pandemic response hinged on vaccination as a silver bullet. By Justin Feldman.
2: Moderna, funded with nearly $1 billion in taxpayer dollars to develop a COVID-19vaccine, sets the highest prevailing market price for the product. The controversy here is that this was the highest price set although the company received 100% of the development costs for the vaccine covered by the U.S. government. .”
where trust in every type of organization and expert has plummeted in the wake of the COVID-19 pandemic, political and social strife, and an economic downturn. Edelman then connects the dots between information hygiene and vaccine hesitancy in this chart. The info hygiene-vaccine gap in the U.S.
Since the introduction of COVIDvaccines in 2021, if not before, Democratic leaders have rolled back mandates and devolved the responsibility of preventing disease to individuals and families.
On December 1, 2021, the CDC issued a press release announcing that it had identified a case of the Omicron variant in the U.S. The rate of inflation was nearly 7% in 2021, which is unprecedented in recent economic history. ” which was originally published on January 5, 2022 on Medium. By Justin Feldman. for the first time.
The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. Looking forward, the test of the sustainability of upwardly-mobile pharma reputation in 2021 and 2022 will be drug pricing.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content